


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+2.30%
+3.49%
+5.19%
BDX
Becton, Dickinson and
$176.66
Strengths

Earnings are forecast to grow

Upgraded on attractively valued
Risk Analysis

Trading above its fair value
BDX Price Performance
$203.48 (-13.18%)
$190.47 (-7.25%)
$193.61 (-8.75%)
$225.98 (-21.82%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Reported a strong earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Trading above its fair value
BDX Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
BDX Street Sentiment is extremely bullish and have positive views on the near-term outlook
BDX has Low risk level
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Feb 13, 2026
Price Target Raised
Buy
Citi
Dec 03, 2025
Reiterate
Overweight
Morgan Stanley
Nov 08, 2025
Reiterate
Neutral
Piper Sandler
BSX
Boston Scientific
75.75
+3.10%
TFX
Teleflex Incorporate
119.02
+6.37%
RMD
ResMed
257.06
+1.78%
IRTC
iRhythm Technologies
140.18
+3.15%
What is BDX current stock price?
What are BDX stock strengths?
What is BDX Risk Level?
What is BDX market cap and volume?
What is BDX current Stock IQ?
Should I buy BDX stock right now?
Is BDX a Strong Buy right now?
What does a 'Strong Buy' rating mean for BDX?
What does a 'Strong Sell' rating mean for BDX?
What factors influence BDX's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
BDX
Becton, Dickinson and
Current Price
$176.66
Runners Also Watch
BSX
Boston Scientific
75.75
+3.10%
TFX
Teleflex Incorporate
119.02
+6.37%
RMD
ResMed
257.06
+1.78%
IRTC
iRhythm Technologies
140.18
+3.15%

BDX Price Performance
$203.48 (-13.18%)
$190.47 (-7.25%)
$193.61 (-8.75%)
$225.98 (-21.82%)
BDX Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Reported a strong earnings
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Trading above its fair value
BDX Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
BDX Street Sentiment is extremely bullish and have positive views on the near-term outlook
BDX has Low risk level
Average key support and resistance price levels
Overall Wall Street Rating
BDX Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued
Risk Analysis

Trading above its fair value
BDX Latest Analysis
Citi Raises Becton Dickinson (BDX) PT to $198 after Life Sciences Sale Update. Becton Dickinson and Company (NYSE:BDX) is included among the 13 Cheapest Dividend Aristocrats to Invest in. On February 11 Citi analyst Joanne Wuensch lifted her price recommendation on Becton Dickinson and Company (NYSE:BDX) to $198 from $185.70 and maintained a Buy rating. The adjustment came after the firm updated its financial model to account for [….]
Fri Feb 13, 2026
Are Wall Street Analysts ish on Becton Dickinson and Company Stock?.
Wed Feb 11, 2026
RSI Alert: Becton Dickinson Now Oversold. The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks according to a proprietary formula designed to identify those stocks that combine two important characteristics &mdash. strong fundamentals and a valuation that looks inexpensive.
Tue Feb 10, 2026
Whats Going On With Becton Dickinson Stock Tuesday?. ) on Monday reported first-quarter 2026 adjusted earnings of $2.91 per share beating .The company reported sales of $5.25 billion slightly above the .The company is providing guidance for fiscal year 2026 for New BD reflecting the separation of its Biosciences and Diagnostic Solutions businesses and the combination with WAT).Becton Dickinson lowers fiscal 2026 adjusted earnings guidance to $12.35-$12.65 per share compared to the consensus of
Tue Feb 10, 2026
Becton Dickinson (BDX) Shares Cross Below 200 DMA. In trading on Tuesday shares of Becton Dickinson &. Co (Symbol: BDX) crossed below their 200 day moving average of $187.19 changing hands as low as $164.41 per share. Becton Dickinson &. Co shares are currently trading up about 1.6% on the day. The chart below shows
Tue Feb 10, 2026
Jim Cramer on Becton Dickinson: I Kind of Really Like the New Company. Becton Dickinson and Company (NYSE:BDX) is one of the stocks in focus on Jim Cramers game plan. Cramer showed ish sentiment toward the company as he said:Now theres been some incredible moves happening in the medical devices distribution space this quarter. The once unsinkable Boston
Tue Feb 10, 2026
Becton Dickinson dips 18% on weak profit outlook. Shares of Becton Dickinson and Company slipped more than 18% on Tuesday after the company lowered its full-year 2026 profit outlook.Following the transaction with Waters Becton Dickinson said it now ...
Tue Feb 10, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.